Density and location of CD3+ and CD8+ tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma

被引:50
|
作者
Zhou, Chen [1 ,2 ]
Wu, Yaping [1 ]
Jiang, Lei [1 ]
Li, Zhongwu [3 ]
Diao, Pengfei [1 ]
Wang, Dongmiao [1 ]
Zhang, Wei [4 ]
Liu, Laikui [1 ,4 ]
Wang, Yanling [1 ]
Jiang, Hongbing [3 ]
Cheng, Jie [1 ,3 ]
Yang, Jianrong [1 ,3 ]
机构
[1] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Oral & Maxillofacial Surg, Wuxi, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Dept Oral & Maxillofacial Surg, Affiliated Stomatol Hosp, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Dept Oral Pathol, Sch Stomatol, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
CD3; CD8; oral squamous cell carcinoma; prognosis; tumor-infiltrating lymphocytes; BREAST-CANCER; NECK-CANCER; SURVIVAL; HEAD; TIL;
D O I
10.1111/jop.12698
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BackgroundTumor-infiltrating lymphocytes (TILs) are regarded as adaptive immune response of the host to cancer cells and valuable prognostic factors. Here, we sought to characterize the densities and locations of CD3(+) and CD8(+) TILs in primary oral squamous cell carcinoma (OSCC) samples and assess their clinicopathological and prognostic significance. MethodsA total number of 169 OSCC samples from 2 independent patient cohorts (Nanjing cohort, 93 cases; Wuxi cohort, 76 cases) were retrospectively collected. The numbers of CD3(+) and CD8(+) TILs at tumor center (CT) and invasive margin (IM) of OSCC were identified by immunohistochemistry and calculated. The optimal cutoff values for CD3(+) and CD8(+) TILs to stratify patients were determined by X-tile software in Nanjing cohort and further utilized in Wuxi cohort. The associations between CD3(+)/CD8(+) TILs and clinicopathological parameters or patient survival were assessed. The prognostic values of CD3(+)/ CD8(+) TILs were evaluated by Cox regression analyses. ResultsCD3(+) and CD8(+) TILs were identified at both CT and IM and enriched at IM. High density of CD3(+) TILs at IM (CD3 IM) was significantly associated with increased overall and disease-specific survival (P<.05). High density of CD8(+) TILs at CT (CD8 CT) was significantly associated with increased overall but not disease-specific survival. Moreover, CD3 IM and CD8 CT were identified as independent prognostic factors for patient survival. ConclusionsOur findings provide further evidence to support the prognostic values of CD3(+) and CD8(+) TILs for OSCC, suggesting that TIL subsets might be viable biomarkers and therapeutic targets with translational significance.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 50 条
  • [41] Machine learning models based on quantitative dynamic contrast-enhanced MRI parameters assess the expression levels of CD3+, CD4+, and CD8+ tumor-infiltrating lymphocytes in advanced gastric carcinoma
    Huang, Huizhen
    Li, Zhiheng
    Wang, Dandan
    Yang, Ye
    Jin, Hongyan
    Lu, Zengxin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma
    Wongpattaraworakul, Wattawan
    Gibson-Corley, Katherine N.
    Choi, Allen
    Buchakjian, Marisa R.
    Lanzel, Emily A.
    Rajan, K. D. Anand
    Simons, Andrean L.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Analysis of tumor-infiltrating lymphocytes in cutaneous squamous cell carcinoma
    Haeffner, AC
    Zepter, K
    Elmets, CA
    Wood, GS
    ARCHIVES OF DERMATOLOGY, 1997, 133 (05) : 585 - 590
  • [44] CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells
    Canale, Fernando P.
    Ramello, Maria C.
    Nunez, Nicolas
    Furlan, Cintia L. Araujo
    Bossio, Sabrina N.
    Serran, Melisa Gorosito
    Boari, Jimena Tosello
    del Castillo, Andres
    Ledesma, Marta
    Sedlik, Christine
    Piaggio, Eliane
    Gruppi, Adriana
    Rodriguez, Eva V. Acosta
    Montes, Carolina L.
    CANCER RESEARCH, 2018, 78 (01) : 115 - 128
  • [45] Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis
    Steele, Keith E.
    Tan, Tze Heng
    Korn, Rene
    Dacosta, Karma
    Brown, Charles
    Kuziora, Michael
    Zimmermann, Johannes
    Laffin, Brian
    Widmaier, Moritz
    Rognoni, Lorenz
    Cardenes, Ruben
    Schneider, Katrin
    Boutrin, Anmarie
    Martin, Philip
    Zha, Jiping
    Wiestler, Tobias
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [46] Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
    Yun Liang
    Weiguo Lü
    Xiaofei Zhang
    Bingjian Lü
    Diagnostic Pathology, 13
  • [47] CD8+ tumor-infiltrating lymphocytes contribute to spontaneous "healing" in HER2-positive ductal carcinoma in situ
    Morita, Michi
    Yamaguchi, Rin
    Tanaka, Maki
    Tse, Gary M.
    Yamaguchi, Miki
    Kanomata, Naoki
    Naito, Yoshiki
    Akiba, Jun
    Hattori, Satoshi
    Minami, Shigeki
    Eguchi, Susumu
    Yano, Hirohisa
    CANCER MEDICINE, 2016, 5 (07): : 1607 - 1618
  • [48] CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
    Parodi, Alessia
    Battaglia, Florinda
    Kalli, Francesca
    Ferrera, Francesca
    Conteduca, Giuseppina
    Tardito, Samuele
    Stringara, Silvia
    Ivaldi, Federico
    Negrini, Simone
    Borgonovo, Giacomo
    Simonato, Alchiede
    Traverso, Paolo
    Carmignani, Giorgio
    Fenoglio, Daniela
    Filaci, Gilberto
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (05) : 851 - 862
  • [49] CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer
    Chen, Jiewei
    He, Qingmei
    Liu, Jun
    Xiao, Yongbo
    Xiao, Canhua
    Chen, Keming
    Xie, Dan
    Zhang, Xinke
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3505 - 3511
  • [50] CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
    Alessia Parodi
    Florinda Battaglia
    Francesca Kalli
    Francesca Ferrera
    Giuseppina Conteduca
    Samuele Tardito
    Silvia Stringara
    Federico Ivaldi
    Simone Negrini
    Giacomo Borgonovo
    Alchiede Simonato
    Paolo Traverso
    Giorgio Carmignani
    Daniela Fenoglio
    Gilberto Filaci
    Cancer Immunology, Immunotherapy, 2013, 62 : 851 - 862